Ładuje się......
Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature
Abstract Background Nivolumab is an immune checkpoint inhibitor targeting programmed death-1 protein and has been approved for the treatment of multiple advanced malignancies. Adverse effects of immune checkpoint inhibitors are distinct from conventional cytotoxic chemotherapy and can be life-threat...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2018-05-01
|
| Seria: | Experimental Hematology & Oncology |
| Hasła przedmiotowe: | |
| Dostęp online: | http://link.springer.com/article/10.1186/s40164-018-0104-y |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|